Clinical Trial: Instant Message-delivered Personalised Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332624) titled 'Instant Message-delivered Personalised Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment' on Dec. 29, 2025.

Brief Summary: This pilot study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment, and to investigate the feasibility and effectiveness of the intervention.

Study Start Date: Sept. 17, 2025

Study Type: INTERVENTIONAL

Condition: Mild Cognitive Impairment (MCI)

Intervention: BEHAVIORAL: Automated instant message-guided neuropsychiatric symptoms management

Participants in intervention group ...